Global Markets

Edgewise Therapeutics to Host Webcast Occasion to Focus on Prime-Line Outcomes from Part 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Jap T

StockWaves By StockWaves 0 Min Read
Edgewise Therapeutics to Host Webcast Occasion to Focus on Prime-Line Outcomes from Part 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Jap T




Edgewise Therapeutics to Host Webcast Occasion to Focus on Prime-Line Outcomes from Part 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Jap T

Share This Article
Previous Article ConnectOne Bancorp Shares Are Not often This Low cost, Analyst Upgrades Inventory And Value Forecast – ConnectOne Bancorp (NASDAQ:CNOB) ConnectOne Bancorp Shares Are Not often This Low cost, Analyst Upgrades Inventory And Value Forecast – ConnectOne Bancorp (NASDAQ:CNOB)
Next Article Maharashtra Drops 6% Luxurious EV Tax After Business, Public Backlash Maharashtra Drops 6% Luxurious EV Tax After Business, Public Backlash
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular